$208 Million is the total value of ARMISTICE CAPITAL, LLC's 29 reported holdings in Q4 2014. The portfolio turnover from Q3 2014 to Q4 2014 was - .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| SPPI | New | SPECTRUM PHARMACEUTICALS INC | $14,220,000 | – | 2,052,000 | +100.0% | 6.83% | – |
| ZGNX | New | ZOGENIX INC | $12,878,000 | – | 9,400,000 | +100.0% | 6.19% | – |
| VNDA | New | VANDA PHARMACEUTICALS INC | $10,425,000 | – | 728,000 | +100.0% | 5.01% | – |
| HPTX | New | HYPERION THERAPEUTICS INC | $10,416,000 | – | 434,000 | +100.0% | 5.00% | – |
| RXDX | New | IGNYTA INC | $10,365,000 | – | 1,513,100 | +100.0% | 4.98% | – |
| SPY | New | SPDR S&P 500 ETF TRput | $10,277,000 | – | 50,000 | +100.0% | 4.94% | – |
| KODK | New | EASTMAN KODAK CO | $10,204,000 | – | 470,000 | +100.0% | 4.90% | – |
| PBY | New | PEP BOYS MANNY MOE & JACK | $9,113,000 | – | 928,000 | +100.0% | 4.38% | – |
| VCRA | New | VOCERA COMMUNICATIONS INC | $8,857,000 | – | 850,000 | +100.0% | 4.26% | – |
| SODA | New | SODASTREAM INTERNATIONAL LTD | $8,652,000 | – | 430,000 | +100.0% | 4.16% | – |
| QLGC | New | QLOGIC CORP | $8,551,000 | – | 642,000 | +100.0% | 4.11% | – |
| RPTP | New | RAPTOR PHARMACEUTICAL CORP | $8,416,000 | – | 800,000 | +100.0% | 4.04% | – |
| WIFI | New | BOINGO WIRELESS INC | $8,207,000 | – | 1,070,000 | +100.0% | 3.94% | – |
| AEGR | New | AEGERION PHARMACEUTICALS INC | $7,790,000 | – | 372,000 | +100.0% | 3.74% | – |
| IAC | New | IAC INTERACTIVECORP | $7,781,000 | – | 128,000 | +100.0% | 3.74% | – |
| TIME | New | TIME INC NEW | $7,629,000 | – | 310,000 | +100.0% | 3.67% | – |
| LF | New | LEAPFROG ENTERPRISES INCcl a | $7,080,000 | – | 1,500,000 | +100.0% | 3.40% | – |
| ATRS | New | ANTARES PHARMA INC | $6,682,000 | – | 2,600,000 | +100.0% | 3.21% | – |
| KZ | New | KONGZHONG CORPsponsored adr | $6,476,000 | – | 1,197,000 | +100.0% | 3.11% | – |
| URBN | New | URBAN OUTFITTERS INC | $6,042,000 | – | 172,000 | +100.0% | 2.90% | – |
| UNTD | New | UNITED ONLINE INC | $5,093,000 | – | 350,000 | +100.0% | 2.45% | – |
| KND | New | KINDRED HEALTHCARE INC | $4,254,000 | – | 234,000 | +100.0% | 2.04% | – |
| BSTC | New | BIOSPECIFICS TECHNOLOGIES CO | $4,055,000 | – | 105,000 | +100.0% | 1.95% | – |
| New | EXELIXIS INCnote 4.250% 8/1 | $3,798,000 | – | 6,678 | +100.0% | 1.82% | – | |
| New | CENVEO CORPnote 7.000% 5/1 | $3,726,000 | – | 3,752 | +100.0% | 1.79% | – | |
| DRRX | New | DURECT CORP | $3,038,000 | – | 3,849,266 | +100.0% | 1.46% | – |
| FHCO | New | FEMALE HEALTH CO | $2,642,000 | – | 674,000 | +100.0% | 1.27% | – |
| UNXLQ | New | UNI PIXEL INC | $1,001,000 | – | 176,000 | +100.0% | 0.48% | – |
| RTRX | New | RETROPHIN INC | $427,000 | – | 34,874 | +100.0% | 0.20% | – |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2015-02-17
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| ENANTA PHARMACEUTICALS INC | 30 | Q3 2023 | 2.7% |
| SPDR S&P 500 ETF TR | 28 | Q3 2023 | 29.5% |
| MADRIGAL PHARMACEUTICALS INC | 27 | Q3 2023 | 2.9% |
| VANDA PHARMACEUTICALS INC | 26 | Q3 2021 | 9.4% |
| REGENERON PHARMACEUTICALS | 25 | Q3 2023 | 3.2% |
| ENERGIZER HLDGS INC NEW | 22 | Q2 2023 | 3.7% |
| ANTARES PHARMA INC | 21 | Q3 2020 | 6.6% |
| INCYTE CORP | 21 | Q3 2023 | 2.8% |
| VOYAGER THERAPEUTICS INC | 21 | Q3 2023 | 2.0% |
| BLUEBIRD BIO INC | 20 | Q4 2021 | 1.8% |
View ARMISTICE CAPITAL, LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Avalo Therapeutics, Inc. | June 28, 2023 | 588,850 | 4.7% |
| Addex Therapeutics Ltd. | February 16, 2023 | 675,295 | 5.0% |
| Arcadia Biosciences, Inc. | February 14, 2023 | 2,675,409 | 10.0% |
| Avinger Inc | February 14, 2023 | 789,400 | 10.0% |
| Baudax Bio, Inc. | February 14, 2023 | 1,165,709 | 5.0% |
| BIORA THERAPEUTICS, INC. | February 14, 2023 | 12,989,648 | 5.7% |
| Bit Digital, Inc | February 14, 2023 | 3,161,889 | 3.7% |
| Bruush Oral Care Inc. | February 14, 2023 | 1,122,922 | 10.0% |
| CATALYST PHARMACEUTICALS, INC.Sold out | February 14, 2023 | 0 | 0.0% |
| Clarus Therapeutics Holdings, Inc. | February 14, 2023 | 2,732,169 | 5.0% |
View ARMISTICE CAPITAL, LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
View ARMISTICE CAPITAL, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.